Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma
Oncologist - United States
doi 10.1634/theoncologist.2019-0657
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2019
Authors
Publisher
Alphamed Press